相关实验视频
Updated: Jan 12, 2026

07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
879
自免疫性肺膜膜蛋白质发生病
Spyros A Papiris1, Maria Kallieri2, Maurizio Zompatori3
1Athens Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Seminars in respiratory and critical care medicine
|November 6, 2025
概括
自身免疫性肺膜蛋白酶 (aPAP) 涉及由于GM-CSF自身抗体而导致表面活性剂的积累. 吸入粒细胞巨细胞殖民地刺激因子 (GM-CSF) 现在是标准治疗,改善了患者的治疗结果.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 罕见疾病 罕见疾病
背景情况:
- 自身免疫性肺气膜蛋白质症 (aPAP) 是一种罕见的疾病,其特点是肺气膜中表面活性剂的积累.
- 它是最常见的肺膜蛋白质病 (PAP) 形式,占90%以上的病例.
- 这种疾病是由对粒细胞巨细胞殖民地刺激因子 (GM-CSF) 的自身抗体引起的,损害了巨细胞功能和表面活性剂清除.
研究的目的:
- 审查自身免疫性肺膜蛋白质症 (aPAP) 的病变发生,诊断和不断发展的治疗策略.
- 突出治疗标准的转变,从全肺洗 (WLL) 转向吸入的GM-CSF.
- 强调aPAP作为一项从长椅到床边科学进步的模型.
主要方法:
- 在过去25年中对aPAP病原和治疗研究的文献综述.
- 分析临床试验数据和流行病学信息.
- 综合目前对GM-CSF自身抗体机制及其影响的理解.
主要成果:
- 由于GM-CSF自身抗体,aPAP的致病性涉及胆固醇排泄和表面活性物清除受膜巨细胞的损害.
- 吸入的GM-CSF已经成为新的护理标准,证明了有效性,并取代了全肺洗 (WLL) 作为主要治疗方法.
- aPAP是一种可治疗和潜在的可逆性疾病,患者的结果得到了显著改善.
结论:
- 自身免疫性肺膜蛋白酶 (aPAP) 是一种科学理解和可治疗的疾病.
- 吸入GM-CSF治疗的发展是一个重大进步,将患者护理从WLL转变为更有效的标准.
- aPAP是成功将实验室发现转化为临床实践的典范,改善了患者的预后.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Hypertension: Classification and Pathogenesis
552
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
552
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K

